Although the immune checkpoint molecule HLA-G has been associated with cancer invasiveness and metastatic spread in various malignant diseases [35,36], we were not able to correlate the total amount of sHLA-G to the clinical status or outcome of EOC patients in a previous study [33]. The gene discussed is HLA-G; the disease is cancer.